Self-cross-linking polyelectrolyte complexes for therapeutic cell encapsulation

Photoinduced polyelectrolyte complexation for the formation of stable films with reversible crosslinking

Thin films formed by complexation of oppositely charged polyelectrolytes have significant potential in applications such as separation membranes, biocompatible or anticorrosion coatings, and drug delivery systems. While layer-by-layer deposition is a reliable method for producing conformal films, this multi-step process limits scalability. In this study, we functionalize polymers with photoactive protecting and crosslinking groups, allowing a one-step approach for preparing polyelectrolyte complex (PEC) films. To achieve this goal, we introduced o-nitrobenzyl and coumarin groups into a polyanion. The o-nitrobenzyl protecting groups can be selectively deprotected upon exposure to 365 nm light, revealing charged pendent groups that initiate polyelectrolyte complexation. Simultaneously, the coumarin units in the copolymers undergo dimerization, enhancing the solvochemical stability of the PEC films. Notably, short-wave UV irradiation (254 nm) enables retrocyclization of the coumarin dimers, returning the PEC film to its uncrosslinked state. These UV-driven deprotection, crosslinking, and de-crosslinking processes provide a versatile and tunable platform for fabricating reversibly crosslinked films. By integrating photoresponsive polymers and reversible covalent linkages, this approach offers new opportunities for designing PEC materials with tunable dynamic properties for advanced applications.

Alginate-Poly[2-(methacryloyloxy)ethyl]trimethylammonium Chloride (PMETAC) Immunoisolating Capsules Prolong the Viability of Pancreatic Islets In Vivo

BACKGROUND/OBJECTIVES

This study focuses on the development and evaluation of novel alginate-poly[2-(methacryloyloxy)ethyl]trimethylammonium chloride (PMETAC) microcapsules for encapsulating pancreatic islets to address insulin deficiency in diabetes.

METHODS

In previous research, we fabricated and characterized PMETAC microcapsules, evaluating their stability and permeability in vitro. This study further probes the capsules in vivo, focusing on the functional activity of the encapsulated islets post-transplantation, their viability extension, and the assessment of the immunoprotective, antifibrotic properties, and biostability of the capsules.

RESULTS

Rabbit-derived islets were encapsulated and transplanted into diabetic rats. The encapsulated islets maintained insulin secretion for up to 90 days, significantly longer than non-encapsulated ones, which ceased functioning after 7 days. Histological analysis demonstrated high biocompatibility of the PMETAC coating, resulting in minimal fibrotic overgrowth around the capsules.

CONCLUSIONS

The study highlights the critical role of immunoprotection and the tendency to reduce fibrosis in prolonging islet function. These findings suggest that PMETAC-coated capsules offer a promising solution for cell-based therapies in diabetes by improving graft longevity and reducing fibrotic overgrowth.

Probing of New Polymer-Based Microcapsules for Islet Cell Immunoisolation

Islet allotransplantation offers a promising cell therapy for type 1 diabetes, but challenges such as limited donor availability and immunosuppression persist. Microencapsulation of islets in polymer-coated alginate microcapsules is a favored strategy for immune protection and maintaining islet viability. This study introduces Poly [2-(methacryloyloxy)ethyl]trimethylammonium chloride (PMETAC) as an innovative coating material for microcapsules. PMETAC enhances biocompatibility and durability, marking a significant advancement in islet encapsulation. Our approach combines alginate with PMETAC to create Langerhans islet microcapsules, simplifying material composition and preparation and ultimately lowering costs and increasing clinical applicability. Our comprehensive evaluation of the stability (including osmotic stability, thermal stability, and culture condition stability) and cytotoxicity of a novel microencapsulation system based on alginate-PMETAC-alginate offers insights into its potential application in islet immunoisolation strategies. Microcapsules with PMETAC content ranging from 0.01 to 1% are explored in the current work. The results indicate that the coatings made with 0.4% PMETAC show the most promising outcomes, remaining stable in the mentioned tests and exhibiting the required permeability. It was shown that the islets encapsulated in this manner retain viability and functional activity. Thus, alginate microcapsules coated with 0.4% PMETAC are suitable for further animal trials. While our findings are promising, further studies, including animal testing, will be necessary to evaluate the clinical applicability of our encapsulation method.

3D Printing of Aqueous Two-Phase Systems with Linear and Bottlebrush Polyelectrolytes

We formed core-shell-like polyelectrolyte complexes (PECs) from an anionic bottlebrush polymer with poly (acrylic acid) side chains with a cationic linear poly (allylamine hydrochloride). By varying the pH, the number of side chains of the polyanionic BB polymers (Nbb), the charge density of the polyelectrolytes, and the salt concentration, the phase separation behavior and salt resistance of the complexes could be tuned by the conformation of the BBs. By combining the linear/bottlebrush polyelectrolyte complexation with all-liquid 3D printing, flow-through tubular constructs were produced that showed selective transport across the PEC membrane comprising the walls of the tubules. These tubular constructs afford a new platform for flow-through delivery systems.

Spectroscopic characterization of the interactions between poly(2-(trimethylamino)ethyl methacrylate) chloride and the xanthene dyes, 2', 7'-difluorofluorescein and 2, 4, 5, 7-tetraiodofluorescein

Intermolecular interactions in buffered aqueous solution between the polycation, poly(2-(trimethylamino)ethyl methacrylate) chloride (pTMAEMC) and two anionic xanthene dyes, 2', 7'-difluorofluorescein (Oregon Green 488) and 2, 4, 5, 7-tetraiodofluorescein (Erythrosin B), are characterized using multiple optical spectroscopic methods. Visible absorption spectroscopy indicates the formation of ground-state pTMAEMC-dye complexes. Benesi-Hildebrand binding isotherm analysis of visible absorption spectra for pTMAEMC-dye mixtures quantifies the strength of binding interactions producing the complexes. For both Oregon Green 488 (OG) and Erythrosin B (EB) in mixtures with pTMAEMC, the concentration of the solution's sodium acetate buffer at a fixed pH alters the binding constants, K_b, suggesting that ionic strength plays a key role in determining the binding affinity of pTMAEMC for the dyes. Comparison of K_b, for the dyes indicates stronger binding of EB under all solution conditions. Steady-state fluorescence emission spectroscopy, fluorescence quenching, excited-state fluorescence lifetime measurements and fluorescence correlation spectroscopy provide complementary data for the interactions between pTMAEMC and the dyes. Mixtures of pTMAEMC with the dyes produce fluorescence enhancements and fluorescence quenching which exhibit a dependence on the buffer concentration used in the mixture. Excited-state lifetime analysis indicates that OG interacts with pTMAEMC through ground-state interactions while EB exhibits both ground-state and excited-state interactions with pTMAEMC. The spectroscopic measurements suggest that a polyelectrolyte effect for pTMAEMC due to ionic strength variation produced by the buffer concentration affects the dye binding profile of the polycation. This conclusion is supported by fluorescence correlation spectroscopy (FCS) analyses of the hydrodynamic diameter changes in pTMAEMC-OG binding in low buffer concentration (low ionic strength) solution. FCS analyses of pTMAEMC-OG mixtures also reveal diversity in the complexes formed in low ionic strength solution suggesting that other xanthene dyes will exhibit similar binding behaviors in mixtures with pTMAEMC as a function of solution ionic strength.

Contribution of polymeric materials to progress in xenotransplantation of microencapsulated cells: a review

Cell microencapsulation and subsequent transplantation of the microencapsulated cells require multidisciplinary approaches. Physical, chemical, biological, engineering, and medical expertise has to be combined. Several natural and synthetic polymeric materials and different technologies have been reported for the preparation of hydrogels, which are suitable to protect cells by microencapsulation. However, owing to the frequent lack of adequate characterization of the hydrogels and their components as well as incomplete description of the technology, many results of in vitro and in vivo studies appear contradictory or cannot reliably be reproduced. This review addresses the state of the art in cell microencapsulation with special focus on microencapsulated cells intended for xenotransplantation cell therapies. The choice of materials, the design and fabrication of the microspheres, as well as the conditions to be met during the cell microencapsulation process, are summarized and discussed prior to presenting research results of in vitro and in vivo studies. Overall, this review will serve to sensitize medically educated specialists for materials and technological aspects of cell microencapsulation.

Glucose-sensitive polyelectrolyte nanocapsules based on layer-by-layer technique for protein drug delivery

The glucose-responsive nanocapsules [CS-NAC/p(GAMA-r-AAPBA)] were readily fabricated with modified chitosan (CS-NAC) and random glycopolymer poly(D-gluconamidoethyl methacrylate-r-3-acrylamidophenylboronic acid) p(GAMA-r-AAPBA) as the alternant multilayered polyelectrolyte hybrid shell via layer-by-layer self-assembly after etching the amino functionalized SiO2 spheres by NH4F/HF. The spherical and hollow structure of nanocapsules was confirmed by TEM analysis and there was no clear collapse found after removal of the sacrificial cores. The reversible zeta potential changes of the nanocapsule materials evaluated the reversible glucose sensitivity. Besides, this system demonstrated a good capacity for encapsulation and loading insulin entrapped in nanocapsules as model protein drug. A good biocompatibility of the material was confirmed by the cell viability. In vitro release of insulin experiments revealed that no obvious release was found in acidic condition and the release could be normally conducted at physiological pH. These results implied that it was feasible for nanocapsules to be used in controlled release drug delivery system.

Bio-Encapsulation for the Immune-Protection of Therapeutic Cells

The design of new technologies for treatment of human disorders is a complex and difficult task. The aim of this article is to explore state of art discussion of various techniques and materials involve in cell encapsulations. Encapsulation of cells within semi-permeable polymer shells or beads is a potentially powerful tool, and has long been explored as a promising approach for the treatment of several human diseases such as lysosomal storage disease (LSD), neurological disorders, Parkinsons disease, dwarfism, hemophilia, cancer and diabetes using immune-isolation gene therapy.

Design and engineering of disulfide crosslinked nanocomplexes of polyamide polyelectrolytes: stability under biorelevant conditions and potent cellular internalization of entrapped model peptide

Counter polyelectrolytes (PEs) having a degradable polyamide backbone and controlled thiolation are prepared. Their nanosized polyelectrolyte complexes (PECs) spontaneously crosslink under ambient conditions via bioreducible disulfide bonds. These PECs are regenerable after centrifugation, and resist degradation by proteases. They are stable to variations of pH and electrolyte concentration, similar to those encountered in biological milieu. However, they are unraveled in reductive conditions. These PECs act as efficient vectors for delivering entrapped cargo. They entrap with high efficiency, and controllably release, fluorescein isothiocyanate (FITC)-insulin (a model peptide) in vitro. Potent cellular internalization of FITC-insulin within human lung cancer cells with high cell viability is demonstrated.

Layer-by-layer assembled polyaspartamide nanocapsules for pH-responsive protein delivery

Biodegradable shell cross-linked nanocapsules were prepared via layer-by-layer assembly of PADH (tertiary amine and hydrazide grafted polyaspartamide) and PACA (carboxyl and aldehyde grafted polyaspartamide) on silica spheres. Both of the polyaspartamide derivatives are water-soluble and biodegradable polymers with a protein-like structure, and obtained by aminolysis reaction of polysuccinimide. The latter is prepared by thermal polycondensation of aspartic acid. Dynamic light scattering and zeta potential measurements were used to analyze the layer-by-layer assembly process. Bovine serum albumin (BSA), as a model protein, was entrapped in the nanocapsules via electrostatic adsorption. Nanocapsules encapsulating BSA were prepared via layer-by-layer assembly on protein-entrapping amino-functionalized silica spheres, hydrazone cross-linking and silica core removal. The BSA release profiles exhibited a pH-dependent behavior. BSA release rate increased significantly as the ambient pH dropped from the physiological pH to acidic. Cell viability study suggests that the obtained polymeric nanocapsules have good biocompatibility. These kinds of novel composite nanocapsules may offer a promising delivery system for proteins.

Surface-induced rearrangement of polyelectrolyte complexes: influence of complex composition on adsorbed layer properties

The adsorption characteristics of two different types of polyelectrolyte complexes (PECs), prepared by mixing poly(allylamine hydrochloride) and poly(acrylic acid) in a confined impinging jet (CIJ) mixer, have been investigated with the aid of stagnation point adsorption reflectometry (SPAR), a quartz crystal microbalance with dissipation (QCM-D), and atomic force microscopy (AFM) using SiO(2) surfaces. The two sets of PEC were prepared by combining high molecular mass PAH/PAA (PEC-A) and low molecular mass PAH/PAA (PEC-B). The PEC-A showed a higher adsorption to the SiO(2) surfaces than the PEC-B. The adsorption of the PEC-A also showed a larger change in the dissipation (ΔD), according to the QCM-D measurements, suggesting that the adsorbed layer of these complexes had a relatively lower viscosity and a lower shear modulus. Complementary investigations of the adsorbed layer using AFM imaging showed that the adsorbed layer of PEC-A was significantly different from that of PEC-B and that the changes in properties with adsorption time were very different for the two types of PECs. The PEC-A complexes showed a coalescence into larger block of complexes on the SiO(2) surface, but this was not detected with the PEC-B. The size determinations of the complexes in solution showed that they were very stable over time, and it was therefore concluded that the coalescence of the complexes was induced by the interaction between the complexes and the surface. The results also indicated that polyelectrolytes can migrate between the different complexes adsorbed to the surface. The results also give indications that the preparation of PEC-B leads to the formation of two different types of polyelectrolyte complexes differing in the amount of polymer in the complexes; i.e., two populations of complexes were formed with similar sizes but with totally different adsorption structures at the solid-liquid interface.

Cross-linked microcapsules formed from self-deactivating reactive polyelectrolytes

Poly(methyl vinyl ether-alt-maleic anhydride) (PMM(0)) was partially hydrolyzed in a 9/1 acetonitrile-d(3)/D(2)O mixture and then diluted with an aqueous buffer and coated onto poly-L-lysine (PLL)-coated calcium alginate capsules. The resulting 50% hydrolyzed polymer (PMM(50)) is bound to the surface-immobilized PLL through both electrostatic and covalent interactions, resulting in a shell-cross-linked hydrogel capsule that is resistant to chemical challenges. Further hydrolysis of PMM(50) in aqueous buffer was monitored by potentiometry and was found to proceed with a half-life time of about 2.5 min at 20 degrees C such that residual anhydride groups not consumed by cross-linking with PLL would be deactivated by hydrolysis within several minutes of shell formation, removing potential sites for undesired protein binding. Initial protein-binding tests involving incubation of the capsules in bovine serum albumin solutions for 24 h showed no indication of protein binding. The effects of coating temperature, PLL concentration and molecular weight, PMM(50) molecular weight, and multiple PLL-PMM(50) coatings on shell morphology and behavior were studied using confocal fluorescence microscopy as well as chemical challenges involving sodium citrate and sodium hydroxide. The resilience of the cross-linked shell improved with increasing concentrations of PLL and decreasing molecular weight of PMM(50), both of which resulted in more polyelectrolyte being bound to the capsule. The permeability of these covalently cross-linked capsules was studied using fluorescently labeled dextrans and was found to be comparable to standard calcium alginate-PLL-alginate (APA) capsules.

Mechanically enhanced microcapsules for cellular gene therapy

Microcapsules bearing a covalently cross-linked coating have been developed for cellular gene therapy as an improvement on alginate-poly(L-lysine)-alginate (APA) microcapsules that only have ionic cross-linking. In this study, two mutually reactive polyelectrolytes, a polycation (designated C70), poly([2-(methacryloyloxy)ethyl]trimethylammonium chloride-co-2-aminoethyl methacrylate hydrochloride) and a polyanion (designated A70), poly(sodium methacrylate-co-2-(methacryloyloxy)ethyl acetoacetate), were used during the microcapsule fabrication. Ca-alginate beads were sequentially laminated with C70, A70, poly(L-lysine) (PLL), and alginate. The A70 reacts with both C70 and PLL to form a approximately 30 microm thick covalently cross-linked interpenetrating polymer network on the surface of the capsules. Confocal images confirmed the location of the C70/A70/PLL network and the stability of the network after 4 weeks implantation in mice. The mechanical and chemical resistance of the capsules was tested with a "stress test" where microcapsules were gently shaken in 0.003% EDTA for 15 min. APA capsules disappeared during this treatment, whereas the modified capsules, even those that had been retrieved from mice after 4-weeks implantation, remained intact. Analysis of solutions passing through model flat membranes showed that the molecular weight cut-off of alginate-C70-A70-PLL-alginate is similar to that of alginate-PLL-alginate. Recombinant cells encapsulated in APA and modified capsules were able to secrete luciferase into culture media. The modified capsules were found to capture some components of regular culture media used during preparation, causing an immune reaction in implanted mice, but use of UltraCulture serum-free medium was found to prevent this immune reaction. In vivo biocompatibility of the new capsules was similar to the APA capsules, with no sign of clinical toxicity on complete blood counts and liver function tests. The increased stability of the covalently modified microcapsules coupled with the acceptable biocompatibility and permeability demonstrated their potential for use as immunoisolation devices in gene therapy.